NASDAQ:ARTC

ArthroCare (ARTC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$1.48
$1.76
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ARTC stock logo

About ArthroCare Stock (NASDAQ:ARTC)

ArthroCare Corporation (ArthroCare) is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology, including its OPUS line of fixation products, as well as re-usable surgical instruments. ArthroCare’s two core product consists of sports medicine and ear, nose, and throat (ENT), as well as other areas, such as spine, wound care, urology and gynecology. It’s Sports Medicine, ENT and other products are marketed and sold through two principal geographic distribution channels: Americas (North and South America) and International (all other geographies). In May 2014, Smith & Nephew PLC acquired the Company.

ARTC Stock News Headlines

Arteche Lantegi Elkartea SA (ARTC)
A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
See More Headlines
Receive ARTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ArthroCare and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ARTC
CUSIP
04313610
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Gayle Wiley
    Chief Human Resource Officer, Senior Vice President
  • Jean A. Woloszko M.D. (Age 56)
    Ph.D., Senior Vice President - Research and Development, Chief Technology Officer
  • Richard W. Rew II (Age 49)
    Senior Vice President, General Counsel, Secretary
  • Scott Schaffner (Age 44)
    Senior Vice President, General Manager - Sports Medicine
  • Fred B. Dinger III
    Senior Vice President, General Manager of ENT
  • James L. Pacek (Age 65)
    Senior Vice President - Global Markets and Sales Operations
  • Bruce C. Prothro (Age 52)
    Chief Regulatory Officer, Senior Vice President - Quality Systems and Assurance
  • Fabiana Lacerca-Allen (Age 47)
    Independent Director

ARTC Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of ArthroCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ArthroCare investors own include General Motors (GM), Halliburton (HAL), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Moderna (MRNA), NantKwest (NK), Pfizer (PFE), Schlumberger (SLB) and Atwood Oceanics (ATW).

This page (NASDAQ:ARTC) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners